The treatment journeyNovember 18, 2026

Your first month on a GLP-1: a week-by-week orientation

The first month is mostly about getting set up, learning how your body responds, and staying in touch with your prescriber. Labels describe gradual dose increases to reduce stomach side effects, and your clinician decides your schedule. This page does not give a dosing plan. It gives a week-by-week set of things to do and notice.

Quick answer

The first month is mostly about getting set up, learning how your body responds, and staying in touch with your prescriber. Labels describe gradual dose increases to reduce stomach side effects, and your clinician decides your schedule. This page does not give a dosing plan. It gives a week-by-week set of things to do and notice.

Week 1: set up

  • Confirm the exact product, strength and form with your prescriber and pharmacy.
  • Read the Medication Guide and the instructions for use that come with your product. Ask the pharmacist to walk through them.
  • Check storage and handling for your product. For Wegovy, the Medication Guide gives the details (Wegovy Medication Guide).
  • Confirm your prescribed schedule with the pharmacist; use the instructions for your exact product.
  • Know who to call, and read the symptom list in the Medication Guide.

Week 2: notice and record

Keep a short daily note: appetite, nausea, bowel changes, fluids, energy, and anything that worries you. Trial reports show stomach symptoms are the most common effects (chart below). The Wegovy Medication Guide says drinking fluids helps reduce the chance of dehydration.

Week 3: check what is changing

Review your notes. Are symptoms mild and improving, or getting worse? The Medication Guide says to tell your healthcare provider right away about nausea, vomiting or diarrhea that does not go away. Severe stomach pain that will not go away is a reason to call your provider right away. For the full product-specific discussion, read nausea on a GLP-1: what may help and when to call.

Week 4: prepare for the check-in

Bring your notes to your follow-up. Ask your clinician what, if anything, should change next, and when. Do not change doses on your own.

Stopping because of adverse reactions in trials

Stopping because of adverse reactions in trials

What the trials say about staying on treatment

In the Wegovy adult trials, 6.8% of people on 2.4 mg and 3.2% on placebo permanently stopped because of adverse reactions. In the Zepbound weight-reduction trials, 4.8%, 6.3% and 6.7% on 5, 10 and 15 mg and 3.4% on placebo did. The Zepbound label says most people who stopped did so in the first few months, mainly for gastrointestinal reasons. Sources: Wegovy label Zepbound label section 6.1 of each.

What this does not establish

This is an orientation checklist, not medical advice. Individual courses differ, and the schedule for your product is set by your prescriber and its label. Trial figures describe groups, not what you will experience.

FAQs

What should I expect in the first month of a GLP-1? Mostly stomach-related effects such as nausea, diarrhea or constipation, which the labels say are most often reported during dose increases.

What should I track? Symptoms, fluids, appetite, and any questions for your clinician.

Where do I find my medicine’s schedule? In the prescribing information and Medication Guide for your exact product, and from your prescriber.

Sources

  1. product label, Wegovy
  2. product label, Zepbound
  3. Wegovy Medication Guide, DailyMed

Source methods and reading limits

Sources checked against Europe PMC abstracts and product-label text: November 17, 2026. Full text was not read for abstract-only claims. Source dates and reading limits are recorded with the supporting references.